Zobrazeno 1 - 10
of 723
pro vyhledávání: '"Y, Neuzillet"'
Autor:
M. Guerin, C. Miran, E. Colomba, M. Cabart, T. Herrmann, S. Pericart, D. Maillet, Y. Neuzillet, A. Deleuze, E. Coquan, M. Laramas, C. Thibault, B. Abbar, B. Mesnard, D. Borchiellini, C. Dumont, E. Boughalem, JL. Deville, M. Cancel, C. Saldana, A. Khalil, G. Baciarello, A. Flechon, J. Walz, G. Gravis
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionUrachal cancer (UrC) is a rare, non-urothelial malignancy. Its natural history and management are poorly understood. Although localized to the bladder dome, the most common histological subtype of UrC is adenocarcinoma. UrC develops from
Externí odkaz:
https://doaj.org/article/76b42f3d7a7a443193133e19ae61062e
Autor:
L. Bardin, C. Fournier, R. Mallet, A. Faix, Y. Neuzillet, P. Mongiat-Artus, X. Rebillard, G. Fournier, X. Game
Publikováno v:
Progrès en Urologie - FMC. 33:F38-F48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad0af4003a287a9b43f152b228ecf528
https://doi.org/10.1016/j.fpurol.2023.03.001
https://doi.org/10.1016/j.fpurol.2023.03.001
Autor:
Y. Soorojebally, Y. Neuzillet, T. Lebret, Y. Allory, F. Descotes, S. Ferlicot, D. Kassab-Chahmi, P.-J. Lamy, S. Oudard, X. Rébillard, C. Roy, M. Roumiguié, M. Rouprêt, F. Audenet
Publikováno v:
Progrès en Urologie. 33:307-318
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f3e65d762dd184e1670e881b8be0efa
https://doi.org/10.1016/j.purol.2023.03.003
https://doi.org/10.1016/j.purol.2023.03.003
Autor:
H.M. Bruins, E. Veskimae, V. Hernandez, Y. Neuzillet, M. Rouanne, R. Cathomas, E.M. Compérat, N.C. Cowan, G. Gakis, E.L. Espinós, A. Lorch, M.J. Ribal, G.N. Thalmann, Y. Yuan, A.G. Van Der Heijden, J.A. Witjes
Publikováno v:
European Urology Open Science, Vol 19, Iss , Pp e1790-e1791 (2020)
Externí odkaz:
https://doaj.org/article/de7b45fd42da45b8bee20e4067063be1
Autor:
Y. Neuzillet, T. Seisen, O. Traxer, Y. Allory, F. Audenet, P. Leon, Y. Loriot, B. Pradère, M. Roumiguié, E. Xylinas, A. Masson-Lecomte, M. Roupret
Publikováno v:
Progrès en Urologie. 32:1164-1194
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c3b642d9aee21bb0bbade53da832f18
https://doi.org/10.1016/j.purol.2022.08.003
https://doi.org/10.1016/j.purol.2022.08.003
Autor:
Y. Neuzillet, F. Audenet, Y. Loriot, Y. Allory, A. Masson-Lecomte, P. Leon, B. Pradère, T. Seisen, O. Traxer, E. Xylinas, M. Roumiguié, M. Roupret
Publikováno v:
Progrès en Urologie. 32:1141-1163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f97b1372bf8f68148e06b53db30ded9
https://doi.org/10.1016/j.purol.2022.07.145
https://doi.org/10.1016/j.purol.2022.07.145
Autor:
Y. Neuzillet, B. Pradère, E. Xylinas, Y. Allory, F. Audenet, Y. Loriot, A. Masson-Lecomte, M. Roumiguié, T. Seisen, O. Traxer, P. Leon, M. Roupret
Publikováno v:
Progrès en Urologie. 32:1102-1140
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5f8a8a73a025364b96e523e2ea10215
https://doi.org/10.1016/j.purol.2022.08.006
https://doi.org/10.1016/j.purol.2022.08.006
Autor:
P. Leon, F. Saint, F. Audenet, M. Roumiguié, Y. Allory, Y. Loriot, A. Masson-Lecomte, B. Pradère, T. Seisen, O. Traxer, E. Xylinas, M. Roupret, Y. Neuzillet
Publikováno v:
Progrès en Urologie. 32:299-311
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2585cb65fa9c26e72fbf66b482e5708e
https://doi.org/10.1016/j.purol.2022.01.004
https://doi.org/10.1016/j.purol.2022.01.004
Autor:
F. Audenet, A. Sotto, M. Roumiguié, Y. Allory, C. Andrejak, P. Leon, Y. Loriot, A. Masson-Lecomte, B. Pradère, T. Seisen, O. Traxer, E. Xylinas, F. Bruyère, M. Roupret, F. Saint, Y. Neuzillet
Publikováno v:
Progrès en Urologie. 32:165-176
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::243665d7bf1879d27851c8e3a74019f9
https://doi.org/10.1016/j.purol.2022.01.001
https://doi.org/10.1016/j.purol.2022.01.001
Publikováno v:
Progrès en Urologie. 32:53-60
Summary Introduction Factors predicting response to adjuvant chemotherapy (AC) are required to identify patients who will most benefit from it. The aim of this study was to evaluate the impact of carcinoma in situ (CIS) at radical cystectomy (RC) on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e777de1d53de15a7977ba06966d24be
https://doi.org/10.1016/j.purol.2021.09.010
https://doi.org/10.1016/j.purol.2021.09.010